OncoSenX, Inc., a late preclinical-stage company developing therapeutics to kill cancer cells based on their…
sciencecityJuly 9, 2019
Type III interferon (IFN-λ) is important for innate immune protection at mucosal surfaces and has…
sciencecityJuly 8, 2019
Relapse after allogeneic hematopoietic cell transplantation (HCT) is the leading cause of death in patients…
sciencecityJuly 5, 2019
New findings show how a genetically aberrant, fused protein promotes a rare form of liver…
sciencecityJuly 5, 2019
Dr. Meghan Koch, an immunologist at Fred Hutchinson Cancer Research Center, has been named a…
sciencecityJuly 4, 2019
Today, President Donald J. Trump announced the recipients of the Presidential Early Career Award…
sciencecityJuly 4, 2019
Learn about the newly funded 2019-2020 Alzheimer's Disease Research Center pilot projects. These one-year projects encourage…
sciencecityJuly 3, 2019
Paul Allen was one of the most intellectually curious people I’ve ever known. Ever since…
sciencecityJuly 3, 2019
Adaptive Biotechnologies’ first day as a public company is one for the record books. Shares…
sciencecityJuly 2, 2019
